Based on these data, it can be inferred that NaB may block the inhibition of NK cell effector functions in CRC by downregulating PCNA expression; disrupting its suppressive interaction with NK cell effectors; and reprogramming both the tumor cells and the tumor microenvironment. The gene discussed is PCNA; the disease is colorectal carcinoma.